Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...
The trail enrolled 123 patients at 23 sites across the US and Europe.
Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results